“Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource‐Limited Egyptian Setting”
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Lamiaa Fadel Alkilany und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Immunology Unit, Cancer Biology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection remains prevalent in multiply transfused patients, even in the era of rigorous donor screening. While the hepatic effects of HCV have been well documented, its influence on malignancy outcomes and mortality remains underexplored. This study evaluated the incidence of HCV among pediatric acute lymphoblastic leukemia (ALL) patients and its impact on treatment interruption, overall survival (OS), and relapse‐free survival. A retrospective analysis of medical records was conducted for 166 ALL patients treated between January 2016 and December 2021 at the Pediatric Oncology and Hematological Malignancies Department, South Egypt Cancer Institute. HCV‐Serology status of all patients was regularly followed up through December 2023. Among the 166 patients, 65 (39.2%) were HCV‐positive. HCV‐positive Patients experienced a significantly higher relapse risk −6.7‐times greater‐than HCV‐negative peers ( p < 0.001). No statistically significant difference was observed in OS between the groups ( p = 0.812). The high incidence of HCV among pediatric ALL patients may represent a risk factor for relapse. Early detection and appropriate management of HCV could enhance patient prognosis and warrant further attention in clinical protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virology and Immunology Unit, Cancer Biology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
- Public Health and Community Medicine Department, Faculty of Medicine, Minia University, Minia, Egypt.
- Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
- Pediatric Oncology and Hematological Malignancies Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
- Division of Pediatric Hematology and Oncology, Department of Pediatrics, Children's Hospital of Central Switzerland, Lucerne, Switzerland.
ORCID-Profile: Lamiaa Fadel Alkilany, Shaza Fadel Alkilany
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Alkilany, L. F., Alkilany, S. F., Gaber, N., Farrag, A., & Osman, A. M. (2025). “Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource‐Limited Egyptian Setting”. Journal of Medical Virology. https://doi.org/10.1002/jmv.70683
Vancouver
Alkilany LF, Alkilany SF, Gaber N, Farrag A, Osman AM. “Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource‐Limited Egyptian Setting”. Journal of Medical Virology. 2025. doi:10.1002/jmv.70683
BibTeX
@article{Alkilany2025,
author = {Alkilany, Lamiaa Fadel and Alkilany, Shaza Fadel and Gaber, Noha and Farrag, Ahmed and Osman, Amira Mahmoud},
title = {“Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource‐Limited Egyptian Setting”},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70683}
}
EUVIMED